THERAPEUTICSMD INC TXMD
COM · Common Stock · CUSIP 88338N107
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersBoca Raton, FL
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $9.94.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 173 |
| Q1 2020 | 145 |
| Q2 2020 | 151 |
| Q3 2020 | 144 |
| Q4 2020 | 162 |
| Q1 2021 | 164 |
| Q2 2021 | 157 |
| Q3 2021 | 151 |
| Q4 2021 | 132 |
| Q1 2022 | 124 |
| Q2 2022 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2020 | 47 | 71 |
| Q4 2020 | 71 | 51 |
| Q1 2021 | 89 | 52 |
| Q2 2021 | 65 | 62 |
| Q3 2021 | 70 | 60 |
| Q4 2021 | 40 | 83 |
| Q1 2022 | 41 | 65 |
| Q2 2022 | 0 | 122 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2021 | $1.1m | $558.0k | 0.51 |
| Q4 2021 | $450.0k | $295.0k | 0.66 |
| Q1 2022 | $183.0k | $93.0k | 0.51 |
| Q2 2022 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| BlackRock Inc. | Sold out | -24.4m |
| VANGUARD GROUP INC | Sold out | -17.4m |
| STATE STREET CORP | Sold out | -7.3m |
| MORGAN STANLEY | Sold out | -7.3m |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -6.6m |
| C WorldWide Group Holding A/S | Sold out | -6.2m |
| Rubric Capital Management LP | Sold out | -5.3m |
| NORTHERN TRUST CORP | Sold out | -3.5m |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | Sold out | -3.4m |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -3.1m |
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 1 | $5.3k | 5 | $143.9k | — |
| Q3 2021 | 4 | $799.2k | 1 | $81.2k | — |
| Q4 2021 | 1 | $580.0k | 1 | $16.1k | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Lido Advisors, LLC 0.00% of their portfolio | 13.4k $133.0k | Reduced -3.8k |
| MBM WEALTH CONSULTANTS, LLC 0.00% of their portfolio | 491 $5.0k | Reduced -29.4k |